Risman Discusses Perils of Hotel Sector for High-Net-Worth Investors
10 December 2018
National Real Estate Investor
Partner Cliff Risman is quoted in an article for National Real Estate Investor, “Hotels Might Be a Good Bet for HNW Investors, But Which Types Should They Focus On? ” about which segments of the hotel sector hold the most potential for strong risk-adjusted yields.
Risman said high-net-worth investors should proceed with caution when investing in the hotel field. Unlike an office building or a warehouse, a hotel is a business with employees, inventory and other concerns, he noted.
“High-net-worth investors who jump into a hotel deal because they think it’s sexy, or because they like having dinner there, many times go away licking their wounds,” he said. “It’s a complicated business.”
Risman said high-net-worth investors should proceed with caution when investing in the hotel field. Unlike an office building or a warehouse, a hotel is a business with employees, inventory and other concerns, he noted.
“High-net-worth investors who jump into a hotel deal because they think it’s sexy, or because they like having dinner there, many times go away licking their wounds,” he said. “It’s a complicated business.”
People
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."